TACRO-CYP5 is a transparent bedside tacrolimus exposure-risk model for autoimmune disease. It combines CYP3A5 genotype, starting dose, kidney and liver context, interacting drugs, and monitoring readiness to distinguish underexposure from toxicity and support early trough-guided titration.
ANIFRO-HZ is an executable, transparent clinical decision-support skill for stratifying herpes zoster concern in systemic lupus erythematosus during or soon after anifrolumab exposure. The bedside problem is not only knowing that zoster risk exists, but recognizing when glucocorticoids, lymphopenia, nephritis-level co-immunosuppression, absent recombinant zoster vaccination, and early symptom patterns create a treatment context that should alter monitoring or escalation.
Osteonecrosis is a clinically meaningful but often underrecognized complication of systemic lupus erythematosus (SLE), especially after repeated pulse methylprednisolone exposure or sustained high cumulative glucocorticoid burden. The diagnostic problem is practical: early hip or groin pain may be normalized until structural injury is advanced, while the real risk context was created earlier by nephritis, steroid intensity, vascular-metabolic factors, and thrombosis biology.
PRES-LUPUS is an executable Python skill for transparent bedside risk-context stratification of posterior reversible encephalopathy syndrome in systemic lupus erythematosus. It addresses a real clinical recognition problem: when acute neurologic symptoms during lupus nephritis, severe hypertension, and high-intensity immunosuppression should trigger urgent PRES exclusion rather than delayed attribution to flare alone.
We present CYCLO-OVA, an executable Python skill for transparent ovarian-failure risk stratification before or during cyclophosphamide exposure in rheumatic and autoimmune disease. The model integrates age, planned cumulative dose, oral daily versus pulse exposure, prior cyclophosphamide exposure, baseline low ovarian reserve or prior amenorrhea, expectation of repeated treatment cycles, other gonadotoxic exposures, fertility goals, GnRH agonist mitigation planning, and availability of less gonadotoxic alternatives.
MMF-PREG is an executable clinical skill for transparent reproductive-safety triage around mycophenolate use in rheumatic and autoimmune disease. It addresses a real bedside problem: fetal-teratogenic exposure risk and preconception transition failure when patients remain on mycophenolate during possible conception, stop it without completed washout, or lack a pregnancy-compatible maintenance plan.
Treatment response in lupus nephritis requires monitoring at 3, 6, and 12 months with specific UPCR, eGFR, and serological targets (Fanouriakis 2020). NEPHRITIS-LN is an executable skill that tracks response trajectories against EULAR/ERA-EDTA complete and partial response criteria.
Lupus nephritis affects 40-60% of SLE patients and is a major predictor of mortality (Almaani 2017). NEFRO-LUP is an executable skill that integrates ISN/RPS 2018 classification, UPCR trajectory, complement trends, anti-dsDNA titers, and treatment response to compute risk of progression.
Lupus nephritis affects 40-60% of SLE patients and remains a leading cause of ESRD. NEPHRITIS-LN is an agent-executable clinical decision support skill that computes a 10-domain weighted composite flare risk score incorporating proteinuria, anti-dsDNA titer/trend, complement C3/C4, eGFR trajectory, urinary sediment, immunosuppression adequacy, prior flare history, serological activity, and biopsy chronicity index.
We present a Bayesian sequential monitoring system for early lupus nephritis detection using serial urinalysis results. A Hidden Markov Model with states corresponding to ISN/RPS lupus nephritis classes (No nephritis, Class II-V) updates posterior probabilities from proteinuria, hematuria, cast patterns, and serologic markers (anti-dsDNA, C3/C4, SLEDAI).